4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0000950170-25-004145
Options or other derivatives
- Chief Financial Officer acquired 275,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Broadfoot Jill Marie Chief Financial Officer | 2025-01-08 | Grant or award · Employee Stock Option (right to buy) | +275,000 | 275,000 | D | ||
Loading xslF345X05/ownership.xml…